BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Ignite II - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Ignite II
X-ORIGINAL-URL:https://gmkb.org
X-WR-CALDESC:Events for Ignite II
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Denver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20240310T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20241103T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20250309T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20251102T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20260308T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20261101T080000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Denver:20250910T110000
DTEND;TZID=America/Denver:20250912T120000
DTSTAMP:20260423T154946
CREATED:20250911T204139Z
LAST-MODIFIED:20250911T204139Z
UID:4493-1757502000-1757678400@gmkb.org
SUMMARY:PGRN 2025 Scientific Meeting
DESCRIPTION:PGRN 2025 Scientific Meeting – in collaboration with ClinPGx \nSeptember 10 – 12 | Missoula\, Montana \nThe Pharmacogenomics Global Research Network Scientific Meeting\, in collaboration with ClinPGx\, will be held at the University of Montana University Center in Missoula\, Montana. \nTo learn more\, visit the conference webpage. Please note: Registration is required.
URL:https://gmkb.org/event/pgrn-2025-scientific-meeting/
LOCATION:University Center\, University of Montana\, Missoula\, MT\, 32 Campus Drive\, Missoula\, MT\, 59812\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250331
DTEND;VALUE=DATE:20250404
DTSTAMP:20260423T154946
CREATED:20240807T182623Z
LAST-MODIFIED:20240807T182623Z
UID:4258-1743379200-1743724799@gmkb.org
SUMMARY:G2MC 8th International Conference
DESCRIPTION:G2MC 8th International Conference \nMarch 31 – April 3 | Colombo\, Sri Lanka \nThe Global Genomic Medicine Consortium (G2MC) 8th International Conference themed “Collaboration Beyond Borders for Global Implementation of Genomic Medicine” will be held in Colombo\, Sri Lanka\, for a combined 4-day workshop/conference hosted by the University of Colombo. \nThe conference takes place at a pivotal time\, as genomic medicine transitions from research discoveries to clinical applications with the potential to significantly improve health outcomes. However\, the pace of integrating these advancements into healthcare systems varies considerably across the globe. \nTo learn more\, visit the conference webpage. Registration information coming soon. Please note: Registration is required.
URL:https://gmkb.org/event/g2mc-8th-international-conference/
LOCATION:University of Colombo\, Colombo\, Sri Lanka
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250318
DTEND;VALUE=DATE:20250323
DTSTAMP:20260423T154946
CREATED:20240807T172205Z
LAST-MODIFIED:20240807T172205Z
UID:4256-1742256000-1742687999@gmkb.org
SUMMARY:2025 ACMG Annual Clinical Genetics Meeting
DESCRIPTION:2025 ACMG Annual Clinical Genetics Meeting \nMarch 18 – 22 | Los Angeles\, California \nThe 2025 ACMG Annual Clinical Genetics Meeting will gather members of the medical genetics community from around the world to learn\, connect and celebrate together in Los Angeles\, California. This four-day meeting offers unique and valuable opportunities to forge meaningful connections\, share interests and celebrate achievements\, while hearing about new discoveries in genetic disorders\, rare diseases\, genome sequencing\, gene therapies and best practices in genetic counseling. \nRegistration\, housing\, and abstract submission open on October 1\, 2024. To learn more and stay updated on meeting information\, visit the ACMG meeting website. Please note: Registration is required.
URL:https://gmkb.org/event/2025-acmg-annual-clinical-genetics-meeting/
LOCATION:Los Angeles Convention Center\, 1201 S Figueroa St\, Los Angeles\, CA\, 90015\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241114
DTEND;VALUE=DATE:20241116
DTSTAMP:20260423T154947
CREATED:20240524T035722Z
LAST-MODIFIED:20240524T035722Z
UID:3964-1731542400-1731715199@gmkb.org
SUMMARY:2024 Precision Health Research Symposium
DESCRIPTION:2024 Precision Health Research Symposium \nNovember 14 – 15 | Medical University of South Carolina \nJoin the Precision Public Health Network for their third conference focused on Advancing Equity through Precision Health. The conference will coincide with MUSC’s second annual Precision Health Research Symposium. \nFor more conference information and to register\, visit the event page. Please note: Registration is required. \n  \nCall for Abstracts \nRegistrants interested in participating in the symposium poster session are invited to submit abstracts. Abstracts should have a maximum of 300 words and abstract submitters must register for Day 1 of the symposium. Abstract submissions close on June 15\, 2024. Abstracts can be submitted here.
URL:https://gmkb.org/event/2024-precision-health-research-symposium/
LOCATION:Medical University of South Carolina\, 171 Ashley Avenue\, Charleston\, SC\, 29425\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241105
DTEND;VALUE=DATE:20241110
DTSTAMP:20260423T154947
CREATED:20240807T170000Z
LAST-MODIFIED:20240807T170519Z
UID:4253-1730764800-1731196799@gmkb.org
SUMMARY:ASHG 2024 Annual Meeting
DESCRIPTION:ASHG 2024 Annual Meeting \nNovember 5 – 9 | Denver\, Colorado \nJoin the American Society of Human Genetics for their 5-day meeting\, which will cover a broad spectrum of topics including new technologies\, applications\, and research to showcase the most compelling genetics and genomics science of the year. \nTo learn more and register\, visit the ASHG meeting webpage. Please note: Registration is required.
URL:https://gmkb.org/event/ashg-2024-annual-meeting/
LOCATION:Colorado Convention Center\, 700 14th St\, Denver\, CO\, 80202\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240905T140000
DTEND;TZID=America/New_York:20240905T150000
DTSTAMP:20260423T154947
CREATED:20240807T193521Z
LAST-MODIFIED:20240807T193521Z
UID:4261-1725544800-1725548400@gmkb.org
SUMMARY:NHGRI Division of Intramural Research Seminar Series
DESCRIPTION:The importance of environmental and ancestral context in genetic risk examination for diverse and admixed populations \nThursday\, September 5 | 2 p.m. ET | Hybrid: In-person and Virtual \nSpeaker: Genevieve Wojcik\, PhD\, MHS\nAssistant Professor\, Johns Hopkins Bloomberg School of Public Health \nAs a statistical geneticist and genetic epidemiologist\, Dr. Wojcik’s research focuses on method development for diverse populations\, specifically in admixed populations. Many of her efforts focus on improving statistical methods for complex trait mapping and polygenic risk scores for these populations to address existing health inequities and ensure downstream translation for all. \nThe second arm of Dr. Wojcik’s research program focuses on the genetic susceptibility to infectious disease and vaccine response\, with an eye towards host-pathogen co-evolution. \nFor more information and to register\, visit the seminar series webpage. Please note: Zoom registration is required for virtual attendees.
URL:https://gmkb.org/event/nhgri-division-of-intramural-research-seminar-series/
LOCATION:Lipsett Amphitheater\, 10 Center Dr.\, Bethesda\, MD\, 20814\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240821
DTEND;VALUE=DATE:20240824
DTSTAMP:20260423T154947
CREATED:20240209T231101Z
LAST-MODIFIED:20240522T145843Z
UID:3877-1724198400-1724457599@gmkb.org
SUMMARY:PRECISE-IHCC Conference 2024
DESCRIPTION:PRECISE-IHCC Conference 2024 | From Cohorts to Clinics: The New Landscape of Global Healthcare \nAugust 21 – 23 | Singapore \nJointly organized by Precision Health Research\, Singapore (PRECISE) and the International Health Cohorts Consortium (IHCC)\, this three-day conference will bring together some 600 thought leaders\, clinicians\, scientists\, biotechs\, and patient advocacy associations from across the world who are at the forefront of precision medicine and public health innovation. \nThemed “From Cohorts to Clinics – The New Landscape of Global Healthcare”\, the conference aims to provide a unique platform to spotlight Singapore’s and the international community’s advancements in precision medicine to provide diverse insights and a broad spectrum of experiences and knowledge. \nTo learn more and register\, visit the event page. Please note: Registration is required. \n  \nCall for Abstracts \nRegistrants are also invited to submit abstracts for poster presentations. Registrants who submit abstracts may have a chance to be shortlisted for an oral presentation at the conference. The deadline for abstract submissions has been extended to May 31\, 2024 at 11:59 p.m. ET. \nAbstracts can be submitted here.
URL:https://gmkb.org/event/precise-ihcc-conference-2024/
LOCATION:One Farrer Hotel\, 1 Farrer Park Station Rd.\, 217562\, Singapore
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240627T090000
DTEND;TZID=America/New_York:20240627T100000
DTSTAMP:20260423T154947
CREATED:20240606T204935Z
LAST-MODIFIED:20240606T204935Z
UID:4004-1719478800-1719482400@gmkb.org
SUMMARY:Value of a Genomic Result in Rare Disease Patients – Sri Lankan Experience
DESCRIPTION:Value of a Genomic Result in Rare Disease Patients – Sri Lankan Experience \nThursday\, June 27\, 2024 | 9 a.m. ET | Virtual \nSpeaker: Dr. Kawmadi Gunawardena \nDr. Gunawardena will discuss the impact of genomic results in rare disease patients by illustrating interesting case scenarios of Sri Lankan patients. \nTo learn more and register\, visit the GGMC Educational Webinar Series webpage. \nPlease note: Registration is required for this webinar.
URL:https://gmkb.org/event/value-of-a-genomic-result-in-rare-disease-patients-sri-lankan-experience/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240611T120000
DTEND;TZID=America/New_York:20240611T130000
DTSTAMP:20260423T154947
CREATED:20240531T183701Z
LAST-MODIFIED:20240531T183701Z
UID:3982-1718107200-1718110800@gmkb.org
SUMMARY:Biomedicine in the Age of Generative AI
DESCRIPTION:Biomedicine in the Age of Generative AI \nTuesday\, June 11 | 12 p.m. ET | Virtual \nSpeaker: James Zou\, PhD\nAssociate Professor\, Biomedical Data Science\, Computer Science\, and Electrical Engineering\nStanford University \nThis talk will explore how to develop and use generative artificial intelligence (AI) to help researchers\, clinicians\, and patients. Dr. Zou will discuss how to use AI to generate recipes for making and validating new drugs and how visual-language AI can help clinicians interpret histology images. Finally\, he will discuss using large language models (LLM) to simplify medical forms and improve informed consent for patients as well as share perspectives on what’s on the new horizon for generative AI. \nZoom Information\nJoin via PC\, Mac\, iOS or Android: https://zoom.us/j/98840587618?pwd=RWpjRzlRK1pPL2lVUWt5ZWE4bmpxQT09\nMeeting ID: 988 4058 7618\nPasscode: 191972
URL:https://gmkb.org/event/biomedicine-in-the-age-of-generative-ai/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240528T090000
DTEND;TZID=America/New_York:20240528T100000
DTSTAMP:20260423T154947
CREATED:20240517T044402Z
LAST-MODIFIED:20240522T144054Z
UID:3953-1716886800-1716890400@gmkb.org
SUMMARY:Integrating Genetics into the Tanzanian Healthcare: An Overview
DESCRIPTION:Integrating Genetics into the Tanzanian Healthcare: An Overview \nTuesday\, May 28 | 9 a.m. ET | Virtual \nSpeaker: Dr. Mohamed Zahir Alimohamed \nDr. Alimohamed will provide an overview of the current landscape and future prospects of integrating genetics into healthcare practices in Tanzania\, beginning by outlining the existing healthcare infrastructure and genetic services available in the country. Next\, Dr. Alimohamed will discuss the challenges and opportunities faced in implementing genetic testing\, counseling\, and treatment options within the Tanzanian healthcare system. \nTo learn more and register\, visit the GGMC Educational Webinar Series webpage. \nPlease note: Registration is required for this webinar.
URL:https://gmkb.org/event/integrating-genetics-into-the-tanzanian-healthcare-an-overview/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240522T110000
DTEND;TZID=America/New_York:20240522T123000
DTSTAMP:20260423T154947
CREATED:20240522T144425Z
LAST-MODIFIED:20240522T144425Z
UID:3956-1716375600-1716381000@gmkb.org
SUMMARY:Working Towards Justice & Genetic Health Literacy in Clinical Genomics
DESCRIPTION:Working Towards Justice & Genetic Health Literacy in Clinical Genomics \nWednesday\, May 22 | 11 a.m. ET | Virtual \nSpeakers:\nDr. Janeth Sanchez\, PhD\, MPH\nProgram Director for Health Equity at National Institutes of Health \nDr. Janina Jeff\, PhD\, MS\nBioinformatics Scientist at Illumina and Host of In Those Genes Podcast \nJoin the UNC Program for Precision Medicine in Health Care (PPMH) for a seminar and panel about working towards justice and genetic health literacy in clinical genomics and the complexity of supporting informed decision making by members of vulnerable or marginalized groups. \nTo learn more and register\, visit the event page. Please note: Registration is required for this seminar.
URL:https://gmkb.org/event/working-towards-justice-genetic-health-literacy-in-clinical-genomics/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240405T083000
DTEND;TZID=America/New_York:20240405T170000
DTSTAMP:20260423T154947
CREATED:20240302T035800Z
LAST-MODIFIED:20240302T035800Z
UID:3907-1712305800-1712336400@gmkb.org
SUMMARY:NCSU Data Science and Environmental Health Science Research Symposium
DESCRIPTION:Data Science and Environmental Health Science Research Symposium \nFriday\, April 5 | 8:30 a.m. ET | NC State Hunt Library \nThis interdisciplinary forum will present the research activities in population genomics\, genomic-driven new approach methodologies and environmental health disparities and address approaches to handling big data. \nFor more information and to register\, visit the symposium webpage.
URL:https://gmkb.org/event/ncsu-data-science-and-environmental-health-science-research-symposium/
LOCATION:NCSU Hunt Library\, 1070 Partners Way\, Raleigh\, NC\, 27606\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240403
DTEND;VALUE=DATE:20240405
DTSTAMP:20260423T154947
CREATED:20240108T033826Z
LAST-MODIFIED:20240108T033826Z
UID:3826-1712102400-1712275199@gmkb.org
SUMMARY:All of Us Researchers Convention
DESCRIPTION:All of Us Researchers Convention \nApril 3-4 | Virtual \nThis free\, virtual event is open to researchers across all disciplines and career stages. It provides an opportunity for researchers who use All of Us data to showcase their work for others who share their interests in precision medicine. Abstract submissions can be on any topic. Both in-progress and previously published research projects are eligible for submission. Submit an abstract by January 19\, 2024 at 11:59 p.m. ET. \nFor more information about the convention and updates on when registration opens\, visit the event website. \nPlease note: Registration is required for this event.
URL:https://gmkb.org/event/all-of-us-researchers-convention/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240328T090000
DTEND;TZID=America/New_York:20240328T100000
DTSTAMP:20260423T154947
CREATED:20240323T034101Z
LAST-MODIFIED:20240323T034101Z
UID:3911-1711616400-1711620000@gmkb.org
SUMMARY:The All of Us Research Program
DESCRIPTION:The All of Us Research Program \nThursday\, March 28 | 9 a.m. ET | Online \nSpeaker: Geoffrey Ginsburg\, MD\, PhD \nDr. Geoffrey Ginsburg is the chief medical and scientific officer of the National Institute of Health (NIH)’s All of Us Research Program\, where he leads the scientific vision and strategy for the program. Previously\, he was founding director of the Center for Applied Genomics & Precision Medicine at Duke University School of Medicine and held senior leadership roles at Millennium Pharmaceuticals Inc. He has influenced precision medicine in the U.S. and internationally\, serving as co-chair of the National Academies’ Roundtable on Genomic and Precision Health\, a founding co-chair of the International HundredK+ Cohorts Consortium\, and founder and president of the Global Genomic Medicine Collaborative (G2MC). \nThis talk will cover the All of Us Research Program—a historic effort to gather data from 1 million or more people in the U.S. to accelerate research and improve health\, with a focus on engaging communities historically underrepresented in biomedical research. Since national launch in 2018\, less than 750\,000 participants have enrolled. Diverse participant partners (about 80% from underrepresented backgrounds including racial/ethnic minority groups\, gender minority groups\, disability status\, access to healthcare\, etc.) are sharing health-related data and biospecimens. All of Us data are housed in the cloud-based Researcher Workbench\, which includes tools\, support resources\, sample data workbooks and more. \nTo learn more and register\, visit the GGMC Educational Webinar Series webpage. \nPlease note: Registration is required for this webinar.
URL:https://gmkb.org/event/the-all-of-us-research-program/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240326T120000
DTEND;TZID=America/New_York:20240326T130000
DTSTAMP:20260423T154947
CREATED:20240302T032504Z
LAST-MODIFIED:20240302T032504Z
UID:3904-1711454400-1711458000@gmkb.org
SUMMARY:Carolina Seminar Series | Ensuring Fairness: At the Crossroads of Equity and Economic Considerations in Precision Medicine
DESCRIPTION:Ensuring Fairness: At the Crossroads of Equity and Economic Considerations in Precision Medicine \nTuesday\, March 26 | 12 p.m. ET | Virtual \nSpeaker: Kate Saylor\, PhD\nFellow\, Ethical\, Legal\, and Social Implications (ELSI) of Genetics and Genomics\,\nPerelman School of Medicine at the University of Pennsylvania \nEfforts to expand access to genomic health and precision medicine have resulted in a proliferation of screening programs for healthy adult populations across the nation. Issues of fairness and equity abound in medicine and are a critical component of assessing implementation of these genomic health and precision medicine efforts. But how can programs such as genomic screening ensure equitable access within a healthcare system that is already characterized by massive health disparities and barriers to equitable access? When and how should cost-effectiveness be considered when designing screening programs and their offerings? How can cost-effectiveness models incorporate justice\, equity and inclusion? In this seminar session\, we will explore these questions and the overall relationship between equity and economic considerations in precision medicine. \nTo learn more and register\, visit the event webpage.
URL:https://gmkb.org/event/carolina-seminar-series-ensuring-fairness-at-the-crossroads-of-equity-and-economic-considerations-in-precision-medicine/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240326
DTEND;VALUE=DATE:20240329
DTSTAMP:20260423T154947
CREATED:20231231T202746Z
LAST-MODIFIED:20231231T202746Z
UID:3807-1711411200-1711670399@gmkb.org
SUMMARY:2024 Precision Medicine Tri-Conference
DESCRIPTION:2024 Precision Medicine Tri-Conference \nMarch 26-28 | San Diego\, CA \nJoin thousands of international thought leaders to discuss the latest research\, technologies\, innovation and business models in precision medicine and precision health. Topics will include innovation and market access strategies for at-home diagnostics\, liquid biopsy and advanced diagnostics for precision oncology\, AI and digital tools\, spatial biology and single-cell multiomics in advancing precision medicine and more. \nTo learn more and register\, visit the conference website. \nPlease note: Registration is required for both in-person and virtual attendees.
URL:https://gmkb.org/event/2024-precision-medicine-tri-conference/
LOCATION:Hilton San Diego Bayfront\, 1 Park Boulevard\, San Diego\, CA\, 92101\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240322T120000
DTEND;TZID=America/New_York:20240322T130000
DTSTAMP:20260423T154947
CREATED:20240229T215532Z
LAST-MODIFIED:20240229T215532Z
UID:3902-1711108800-1711112400@gmkb.org
SUMMARY:Ethical Aspects of AI in Biomedical Research: The NIH Bridge to AI Initiative
DESCRIPTION:Ethical Aspects of AI in Biomedical Research: The NIH Bridge to AI Initiative \nFriday\, March 22 | 12 p.m. ET | Hybrid: 321 MacNider Hall & Virtual \nSpeaker: Vardit Ravitsky\, PhD\nPresident and CEO\, The Hastings Center\nSenior Lecturer on Global Health and Social Medicine\, Harvard Medical School\nProfessor\, University of Montréal \nDr. Ravitsky will be speaking at the UNC Center for Bioethics’ Research Ethics Grand Rounds Merrimon Lecture. She is the President and CEO of The Hastings Center\, an independent\, nonpartisan bioethics research institute that is among the most prestigious bioethics and health policy institutes in the world. Dr. Ravitsky joins the Center from the University of Montreal where she was Professor at the Bioethics Program\, School of Public Health. She is also a Senior Lecturer on Global Health and Social Medicine at Harvard Medical School. She received her PhD from Bar-Ilan University in Israel\, her MA from the University of New Mexico\, and her BA from the Sorbonne University in Paris\, France. Dr. Ravitsky runs an active research program and holds several positions on advisory boards. Her research in bioethics focuses on ethical\, legal\, and social implications of genomics and assisted reproductive technologies\, with an emphasis on emerging biotechnologies and their implications for women’s autonomy and for disability rights. She also studies the ethics of AI in biomedicine. \nTo learn more\, visit the event webpage. \nZoom Webinar Link | Passcode: 004091
URL:https://gmkb.org/event/ethical-aspects-of-ai-in-biomedical-research-the-nih-bridge-to-ai-initiative/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240312
DTEND;VALUE=DATE:20240317
DTSTAMP:20260423T154947
CREATED:20231231T050844Z
LAST-MODIFIED:20231231T050844Z
UID:3804-1710201600-1710633599@gmkb.org
SUMMARY:2024 ACMG Annual Clinical Genetics Meeting
DESCRIPTION:2024 ACMG Annual Clinical Genetics Meeting \nMarch 12-16 | Toronto\, Canada \nThe ACMG sponsors an Annual Clinical Genetics Meeting and other events offering educational content in clinical genetics with the purpose of serving its members\, other healthcare professionals and the public. Experience the transformation of medical genetics as treatments can increasingly be tailored with precision medicine and therapeutics. \nTo learn more and register\, visit the meeting website. \nPlease note: Registration is required for in-person attendance and does not include session recordings. ACMG’s Digital Edition for recordings can be purchased separately and will be made available after the conference.
URL:https://gmkb.org/event/2024-acmg-annual-clinical-genetics-meeting/
LOCATION:Metro Toronto Convention Center\, 255 Front St W\, Toronto\, Ontario\, M5V 2W6\, Canada
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240229T090000
DTEND;TZID=America/New_York:20240229T100000
DTSTAMP:20260423T154947
CREATED:20231106T001846Z
LAST-MODIFIED:20240226T010923Z
UID:3593-1709197200-1709200800@gmkb.org
SUMMARY:Translating Science from Bench to Bedside: A Case for Extracellular Vesicles
DESCRIPTION:Translating Science from Bench to Bedside: A Case for Extracellular Vesicles \nThursday\, February 29 | 9 a.m. ET | Online \nSpeaker: Dr. Carlos Salomon Gallo \nDr. Salomon is the head of the Translational Extracellular Vesicles in Obstetrics and Gynae-Oncology Group\, NHMRC Investigator Fellow and is considered a worldwide authority on extracellular vesicles (EVs) biomarkers for complications of pregnancies and ovarian cancer (OC). In the last 10 years\, Dr. Salomon’s primary research and commercialization activities have focused on the identification and validation of biomarkers\, and development of In Vitro Multivariate Index Assays for clinically relevant complications (including ovarian cancers\, and obstetrical syndromes) and their translation into clinical applications. He is a pioneer in investigating the release of EVs by the placenta and tumor cells and their utility as a biomarker for a wide range of pregnancy complications and OC. \nThis talk will cover the burgeoning field of EVs signaling holds the potential to revolutionize our understanding of cancer biology and offers new avenues for non-invasive diagnostics and therapeutic interventions. EVs have been implicated in various aspects of cancer progression\, including tumor initiation\, metastasis\, and response to therapy. From the early stages of tumor development\, tumor-derived EVs are detectable in the circulation. \nTo learn more and register\, visit the GGMC Educational Webinar Series webpage. \nPlease note: Registration is required for this webinar. \n 
URL:https://gmkb.org/event/translating-science-from-bench-to-bedside-a-case-for-extracellular-vesicles/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240228T120000
DTEND;TZID=America/New_York:20240228T130000
DTSTAMP:20260423T154947
CREATED:20240226T030620Z
LAST-MODIFIED:20240226T030731Z
UID:3896-1709121600-1709125200@gmkb.org
SUMMARY:Immune (check point) Related Adverse Events
DESCRIPTION:Immune (check point) Related Adverse Events \nWednesday\, February 28 | 12 p.m. ET | Online \nSpeaker: Frances Collichio\, MD\, Professor of Medicine\, UNC Chapel Hill \nDr. Collichio will review the common and uncommon side effects of immune check point inhibitors. She will also discuss the relatively new concept of delayed immune related events. \nTo learn more and register\, visit the event webpage. \nPlease note: Registration is required for this webinar.
URL:https://gmkb.org/event/immune-check-point-related-adverse-events/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240215T130000
DTEND;TZID=America/New_York:20240215T140000
DTSTAMP:20260423T154947
CREATED:20231229T052112Z
LAST-MODIFIED:20231229T052112Z
UID:3800-1708002000-1708005600@gmkb.org
SUMMARY:Population Screening for Hereditary Hemochromatosis More than a Quarter Century After Gene Discovery – Current Status and the Path Forward
DESCRIPTION:Population Screening for Hereditary Hemochromatosis More than a Quarter Century After Gene Discovery –\nCurrent Status and the Path Forward \nThursday\, February 15 | 1-2 p.m. ET | Virtual \nSpeakers: Paul C. Adams\, MD\, Professor\, Division of Gastroenterology\, Western University \nGail P. Jarvik\, MD\, PhD\, Head and Professor\, Division of Medical Genetics\, University of Washington \nKris V. Kowdley\, MD\, FACP\, FACG\, AGAF\, FAASLD\, Director\, Liver Institute Northwest \nIn this webinar\, speakers will discuss how knowledge about hereditary hemochromatosis (HH) has evolved since the discovery of the HFE gene in 1997\, current opportunities for clinical and public health action to prevent disease\, and future research priorities to advance case detection and reduce clinical complications from HH. \nTo learn more and register\, visit the CDC events page. \nPlease note: Registration is required for this webinar.
URL:https://gmkb.org/event/population-screening-for-hereditary-hemochromatosis-more-than-a-quarter-century-after-gene-discovery-current-status-and-the-path-forward/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240215T090000
DTEND;TZID=America/New_York:20240215T100000
DTSTAMP:20260423T154947
CREATED:20240209T230341Z
LAST-MODIFIED:20240209T230341Z
UID:3874-1707987600-1707991200@gmkb.org
SUMMARY:Personalized Therapeutics: Clinical Reality and Future Challenges
DESCRIPTION:Personalized Therapeutics: Clinical Reality and Future Challenges \nThursday\, February 15 | 9 a.m. ET | Virtual \nSpeaker: George P. Patrinos \nDr. Patrinos is a professor of pharmacogenomics and pharmaceutical biotechnology in the University of Patras’ (Greece) Department of Pharmacy\, and holds adjunct professorships at Erasmus MC\, Faculty of Medicine\, Rotterdam (the Netherlands) and the United Arab Emirates University\, College of Medicine\, Department of Genetics and Genomics\, Al-Ain (UAE). He also served for 12.5 years as full member and Greece’s National Representative in the CHMP Pharmacogenomics Working Party of the European Medicines Agency (EMA) and as Chair of the Global Genomic Medicine Collaborative (G2MC) since 2018. \nAbout the Talk: This talk will provide a summary of the PREPARE and Em-HEART clinical studies in psychiatry and cardiology\, and ethical and regulatory challenges in the field of pharmacogenomics. \nTo learn more and register\, visit the GGMC Educational Webinar Series webpage. \nPlease note: Registration is required.
URL:https://gmkb.org/event/personalized-therapeutics-clinical-reality-and-future-challenges/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240208T140000
DTEND;TZID=America/New_York:20240208T150000
DTSTAMP:20260423T154947
CREATED:20240108T025319Z
LAST-MODIFIED:20240108T025711Z
UID:3821-1707400800-1707404400@gmkb.org
SUMMARY:Duke Genomic Seminar Series
DESCRIPTION:A platform approach to develop and deploy CRISPR-Cas based experimental therapies for inborn errors of immunity in an academic/nonprofit setting \nThursday\, February 8 | 2-3 p.m. ET | Bryan Neurobiology Research Building\, Rm 103 \nSpeaker: Fyodor Urnov\, PhD\nProfessor of Molecular & Cellular Biology\, University of California\, Berkeley\nDirector of Technology & Translation\, Innovative Genomics Institute \nThe vast majority of diseases clinically tractable by genome editing using current-state technology are not the targets of active preclinical or clinical development. Addressing this issue will require more involvement of the academic/nonprofit sector\, but despite an existing charted path for advancing genome editing of specific cell types and tissues (such as T cells\, hematopoietic stem cells\, the liver\, and the retina) to the clinic\, there presently is only one open US IND for genome editing by an all-academic group. A key reason is that the current manufacturing\, regulatory\, and healthcare economics environment is not configured to maximize clinical impact of a technology like CRISPR-Cas. Under the framework that exists today\, a pediatric patient newly diagnosed with a terminal illness such as a severe inborn error of immunity due to a never-before-seen but clinically editable mutation and a life expectancy of < 1 yr will have to wait ~3.5 years until a gene editing medicine is engineered\, tested\, and manufactured at an approximate total cost of $9m. An actionable path through this status quo is to develop and clinically derisk a dedicated nonclinical development path for use in academic/nonprofit settings in N=1/rare situations of dire medical need. From a technology standpoint\, this will require comprehensive leveraging of the intrinsically platform nature of CRISPR-Cas gene editing. The Innovative Genomics Institute in close partnership with clinicians at UCSF and UCLA is developing such a platform focused on inborn errors of immunity\, where ca 112\,000 known patients suffering from 505 currently known diseases lack even a single open trial for genome editing open at the present time. \nTo learn more\, visit Duke’s Genomic Seminar Series page. \nPlease note: This seminar series occurs quarterly with some events occurring virtually only and others in-person with streaming options.
URL:https://gmkb.org/event/duke-genomic-seminar-series/
LOCATION:Duke Neurobiology Research Center\, 311 Research Drive\, Durham\, NC\, 27710\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240111T150000
DTEND;TZID=America/New_York:20240111T160000
DTSTAMP:20260423T154947
CREATED:20231231T032420Z
LAST-MODIFIED:20231231T032420Z
UID:3802-1704985200-1704988800@gmkb.org
SUMMARY:Global Diversity\, Local Context: The Role of Ancestry\, Genetics\, and Environment on Human Health
DESCRIPTION:Global Diversity\, Local Context: The Role of Ancestry\, Genetics\, and Environment on Human Health \nThursday\, January 11 | 3-4 p.m. ET | In-person & Virtual \nSpeaker: Genevieve Wojcik\, PhD\, MHS\nGenetic Epidemiologist and Assistant Professor of Epidemiology\nJohns Hopkins Bloomberg School of Public Health \nDr. Wojcik’s research focuses on understanding the role of ancestry in genetic risk and developing solutions to address health inequities for diverse and admixed populations\, as well as genetic susceptibility to infectious disease. Her most recent work explores the interaction of genetic ancestry and environment in admixed populations and downstream consequences for genetic risk prediction. Dr. Wojcik is a member of multiple NIH consortia\, including the Population Architecture using Genomics and Epidemiology (PAGE) Study\, the Clinical Genome Resource (ClinGen)\, and the Polygenic Risk Methods in Diverse Populations (PRIMED) Consortium. \nThe Genomics and Health Disparities Lecture Series was formed to enhance opportunities for dialogue about how innovations in genomics research and technology can impact health disparities. Topics will range from basic science to translational research. \nTo learn more and register\, visit the lecture series page. \nPlease note: Zoom registration is required for virtual attendees.
URL:https://gmkb.org/event/global-diversity-local-context-the-role-of-ancestry-genetics-and-environment-on-human-health/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240104T120000
DTEND;TZID=America/New_York:20240104T130000
DTSTAMP:20260423T154947
CREATED:20231219T032932Z
LAST-MODIFIED:20231219T032932Z
UID:3770-1704369600-1704373200@gmkb.org
SUMMARY:An Overview of Applied Machine Learning in Medicine at UNC
DESCRIPTION:An Overview of Applied Machine Learning in Medicine at UNC \nThursday\, January 4 | 12-1 p.m. ET | 4th Floor Old Clinic Auditorium or Online \nSpeaker: Amanda Nelson\, MD\nAssociate Professor of Medicine\, UNC-Chapel Hill \nA discussion on the application of AI tools to answer clinical questions around diagnosis\, phenotyping\, prognosis\, and precision medicine using examples from investigators at UNC. \n  \nWebEx Information: \nhttps://uncsom.webex.com/uncsom/j.php?MTID=m893f54367d9d2ac90bbac612e815bf88\nMeeting number (access code): 2314 463 7243\nMeeting password: V!rtu@lmgr22
URL:https://gmkb.org/event/an-overview-of-applied-machine-learning-in-medicine-at-unc/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231221T090000
DTEND;TZID=America/New_York:20231221T100000
DTSTAMP:20260423T154947
CREATED:20231219T032454Z
LAST-MODIFIED:20231219T032454Z
UID:3767-1703149200-1703152800@gmkb.org
SUMMARY:Personalized Risk Assessment for Early Detection of Cancer
DESCRIPTION:Personalized Risk Assessment for Early Detection of Cancer \nThursday\, December 21 | 9 a.m. ET | Online \nSpeaker: Dr. Nora Pashayan \nDr. Pashayan is a Professor of the Epidemiology of Aging and honorary Consultant in Public Health Medicine at the University of Cambridge.  She is a cancer epidemiologist\, a clinician with specialties in both Family Medicine and Public Health Medicine\, and the Director of Training for the International Alliance for Cancer Early Detection. Dr. Pashayan’s primary research field is cancer early detection\, risk stratification\, and population-level screening.  Her research focuses on understanding disease courses\, evaluating screening strategies\, and implementation of novel screening strategies. \nThis talk will introduce the concept of risk-stratified cancer screening and explore the essential considerations for implementation of such a screening program. Examples on integration and implementation will be drawn from the ongoing Canadian study\, PERSPECTIVE I&I. \nTo learn more and register\, visit the GGMC Educational Webinar Series page. \nPlease note: Registration is required for this webinar.
URL:https://gmkb.org/event/personalized-risk-assessment-for-early-detection-of-cancer/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231214T140000
DTEND;TZID=America/New_York:20231214T150000
DTSTAMP:20260423T154947
CREATED:20230920T160637Z
LAST-MODIFIED:20230920T160637Z
UID:3494-1702562400-1702566000@gmkb.org
SUMMARY:NHGRI Division of Intramural Research Seminar
DESCRIPTION:Thursday\, December 14 | 2 – 3 p.m. | Bethesda\, MD & Online \nThe Division of Intramural Research (DIR) sponsors a monthly series of talks by intramural and special guest speakers celebrating genetics and genomics research. Speakers are selected by NHGRI intramural faculty and trainees and cover research topics of interest to a wide audience. \nAll seminars are free and open to the public. Seminar titles and other details are updated on the NHGRI website as information becomes available. \nSpeaker:\nMarius Wernig\, M.D.\, Ph.D.\nProfessor in the Departments of Pathology and Chemical and Systems Biology\nStanford University School of Medicine \nHosts: William Gahl\, May Christine Malicdan and Marie Morimoto \n\nView past presentations\, learn more about upcoming seminars\, and register to attend on the NHGRI website.
URL:https://gmkb.org/event/nhgri-division-of-intramural-research-seminar-4/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231206T160000
DTEND;TZID=America/New_York:20231206T171500
DTSTAMP:20260423T154947
CREATED:20231129T162532Z
LAST-MODIFIED:20231129T162532Z
UID:3618-1701878400-1701882900@gmkb.org
SUMMARY:Carolina Seminar Series | Precision Medicine Research and Novel Clinical Offerings: Ensuring Equitable Impact Through Implementation Science
DESCRIPTION:Precision Medicine Research and Novel Clinical Offerings: Ensuring Equitable Impact Through Implementation Science \nWednesday\, December 6 | 4 p.m. ET | Online \nSpeakers: Caitlin Allen\, PhD\, MPH\nAssistant Professor\, Medical University of South Carolina \nElizabeth Mayer-Davis\, PhD\, RD\nBoshamer Distinguished Professor of Nutrition and Medicine\, UNC-Chapel Hill \nAs technologies and health interventions expand at a rapid rate in healthcare\, many providers and patients desire quick and efficient incorporation of these new offerings in to practice.  The field of implementation science can be critical in studying the barriers and facilitators to bring options previously available only in the research realm to the clinic. The design and development of health interventions are increasingly informed by implementation science theories\, models\, and frameworks to emphasize diverse reach and improve adoption and increase health equity in under served and marginalized communities. By testing new clinical offerings with implementation science methodologies\, we can improve the quality of health practices for all patients while promoting equity and inclusion and ensuring that the availability of novel clinical offerings does not exacerbate existing health disparities. \nTo learn more and register\, visit the UNC events page. \nPlease note: Registration is required for this seminar.
URL:https://gmkb.org/event/carolina-seminar-series-precision-medicine-research-and-novel-clinical-offerings-ensuring-equitable-impact-through-implementation-science/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231130T120000
DTEND;TZID=America/New_York:20231130T130000
DTSTAMP:20260423T154947
CREATED:20230831T124810Z
LAST-MODIFIED:20230831T124810Z
UID:3488-1701345600-1701349200@gmkb.org
SUMMARY:Rapid Genome Sequencing for Diagnosing Critically Ill Infants and Children: From Evidence to Equitable Implementation
DESCRIPTION:Rapid Genome Sequencing for Diagnosing Critically Ill Infants and Children: From Evidence to Equitable Implementation \nThursday\, November 30 | 12-1 p.m. ET | Online \nSpeakers: Dr. Stephen F. Kingsmore\, president/CEO of Rady Children’s Institute for Genomic Medicine (RCIGM) \nTo learn more and register\, visit the CDC event page. \nPlease note: Registration is required for this webinar.
URL:https://gmkb.org/event/rapid-genome-sequencing-for-diagnosing-critically-ill-infants-and-children/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231115T120000
DTEND;TZID=America/New_York:20231115T131500
DTSTAMP:20260423T154947
CREATED:20231029T194313Z
LAST-MODIFIED:20231029T194633Z
UID:3573-1700049600-1700054100@gmkb.org
SUMMARY:NASEM | Roundtable on Genomics and Precision Health - Strategic Plan Reflection on the Roundtable's Work Since 2020
DESCRIPTION:Roundtable on Genomics and Precision Health – Strategic Plan Reflection on the Roundtable’s Work Since 2020 \nWednesday\, November 15 | 12 p.m. ET | Online \nThe Roundtable on Genomics and Precision Health will host a virtual event to highlight the work of the Roundtable since the adoption of its strategic plan in 2020. Speakers will provide their perspectives on the goals and key takeaways heard from workshop and event speakers as well as look ahead to what comes next. Public events include: \n\nImproving Diversity of the Genomics Workforce: A Workshop (2021)\nViews & Voices: Reporting Genetics and Genomics (2022)\nRealizing the Potential of Genomics across the Continuum of Precision Health Care: A Workshop (2022)\nNext-Generation Screening – The Promise and Perils of DNA Sequencing of Newborns at Birth: A Workshop (2023)\n\nThe event will be accessible via webinar. Learn more and register on the event page.
URL:https://gmkb.org/event/nasem-roundtable-on-genomics-and-precision-health-strategic-plan-reflection-on-the-roundtables-work-since-2020/
LOCATION:Virtual
END:VEVENT
END:VCALENDAR